
Sign up to save your podcasts
Or
Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer? Credit available for this activity expires: 3/27/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990129?ecd=bdc_podcast_libsyn_mscpedu
4.3
2323 ratings
Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer? Credit available for this activity expires: 3/27/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990129?ecd=bdc_podcast_libsyn_mscpedu
13 Listeners
316 Listeners
107 Listeners
171 Listeners
866 Listeners
498 Listeners
687 Listeners
18 Listeners
278 Listeners
256 Listeners
3,321 Listeners
135 Listeners
1,101 Listeners
8,002 Listeners
194 Listeners
60 Listeners
8 Listeners
428 Listeners
313 Listeners